Menu
TVG has established a pipeline of animal vaccines to address infectious diseases in animals that have serious commercial impact on livestock production, address major unmet needs in companion animal health or are zoonotic, transferred from animals to humans.
We have an international network of collaborators and have received funding through a combination of commercial development contracts and grant sponsors, including the UK, US and Chinese governments.
Overview of TVG’s current R&D pipeline.
Initially funded by Innovate UK and the Chinese government. Latterly internally funded.
In collaboration with the Pirbright Institute.
Initially funded by ECO Animal Health and latterly internally funded.
Initially funded by ECO Animal Health and latterly internally funded.
Internally funded.
Internally funded.
Internally funded.
Internally funded.
In collaboration with University of Liège and University of Plymouth.
Initial activities funded by BactiVac, ongoing work internally funded.
Funded by Defra, ongoing work internally funded.
In collaboration with UC Davis, Heinrich Pette Institute, University of Western Australia, University of Idaho, University of Glasgow, University of Makeni and the National Institute of Allergy and Infectious Diseases.
Funded by DARPA.
In collaboration with UC Davis, Heinrich Pette Institute, University of Western Australia, University of Idaho, University of Glasgow, University of Makeni and the National Institute of Allergy and Infectious Diseases.
Funded by DARPA.